Dr. Axe Wire · Advanced therapies · health

Enzyme NNMT Drives Hormone Overload In Mouse Ovary Cells Study

A mouse cell study maps how one enzyme locks ovaries into a cycle of excess androgen, a mechanism behind PCOS-like metabolic conditions.

By Dr. Axe Editorial Team · October 17, 2026 · 1 source · Watch

A study published October 16, 2026 in Nature Metabolism found that an enzyme called NNMT drives a self-sustaining hormone overload loop in mouse ovarian cells, a mechanism behind a condition researchers call polyendocrine metabolic ovarian syndrome (PMOS), which overlaps with features of PCOS.

Researchers studying mouse granulosa cells, the cells surrounding developing eggs, found that overexpressing the enzyme nicotinamide N-methyltransferase (NNMT) reduced a mark on histone proteins called H3K27me3, which normally helps keep certain genes switched off. That drop increased expression of a receptor called RARB (retinoic acid receptor beta), which in turn amplified the ovary's production of androgens, the hormones elevated in conditions like PCOS. Sample size was not reported. The excess androgen then further suppressed the H3K27me3 mark, creating what the authors describe as a feedforward loop that locks cells into sustained hyperandrogenism and disrupts the normal development of ovarian follicles. In PMOS mouse models, pharmacologically blocking NNMT restored the H3K27me3 mark, broke the RARB-androgen feedback circuit, and improved both metabolic and hormonal measures, according to the study.

Histone marks like H3K27me3 work like dimmer switches on genes, turning them down without changing the underlying DNA sequence; that is general cell biology, not something this study measured directly. What the authors do state as their own finding is that the NNMT-H3K27me3-RARB-androgen chain links methionine processing, a basic metabolic pathway, to the epigenetic changes that sustain excess androgen production in PMOS. They describe NNMT itself as a tractable drug target based on this mechanism.

How the NNMT feedback loop unfolds in mouse ovarian cells

Oct 16, 2026NNMT overexpression reduces H3K27me3 mark in mouse granulosa cells
Oct 16, 2026Reduced H3K27me3 raises RARB expression, boosting ovarian androgen synthesis
Oct 16, 2026Excess androgen further suppresses H3K27me3, sustaining the feedback loop
Oct 16, 2026Pharmacological NNMT inhibition restores H3K27me3 and improves PMOS model outcomes

Nature Metabolism, 2026, Huang et al.

This is mouse cell and animal model evidence, not a human clinical trial, and the record does not report how many cells or animals were studied. Whether an NNMT-blocking drug would be safe or effective in women with PCOS or related conditions remains untested.

Dr. Axe’s Take

This is exactly the kind of mechanism I want to see chased down, because it finally gives a molecular explanation for why hyperandrogenism in PCOS can feel so locked in and hard to break. Until human trials exist, my approach stays upstream of this pathway: supporting methionine metabolism through B vitamins, choline-rich foods like eggs, and liver-supportive nutrients, while working on insulin sensitivity through resistance training, fiber, and minimizing processed sugar, since insulin resistance itself drives ovarian androgen production. I would not wait on a future NNMT drug to start addressing the metabolic side of this today.

— Dr. Axe

Take the Hormone Balance Quiz →

Story summary

Who: Mouse granulosa cells (ovarian support cells); sample size not reported
Design: Nnmt overexpression study in mouse granulosa cells, plus NNMT inhibition in PMOS mouse models
Dose: Not applicable; genetic overexpression and pharmacological NNMT inhibition studied, doses not reported
Primary result: Nnmt overexpression reduced H3K27me3, raised RARB expression, and increased ovarian androgen synthesis in a self-sustaining loop
Secondary: NNMT inhibition restored H3K27me3, disrupted the RARB-androgen feedback circuit, and improved metabolic and hormonal measures in PMOS mouse models
Funding / conflicts: Funder listed in the journal record: National Natural Science Foundation of China. Conflicts not reported in the abstract.
Date: Oct 16, 2026